Novel and traditional biomarkers of bone turnover in postmenopausal women

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 1, 2003, Pages 74-78

  Pohlídal, Antonín ^a   Hušek, Petr ^b   Palicka, Vladimír ^c   Slabík, David ^a   Hill, Martin ^b   Matucha, Petr ^b  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Biomarkers; Bone turnover; Factor analysis; Postmenopausal women

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; COLLAGEN; DEOXYPYRIDINOLINE; DIPEPTIDE; HYDROXYPROLINE; OSTEOCALCIN; PEPTIDE DERIVATIVE; PROCOLLAGEN C PROTEINASE; PROLINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE DISEASE; BONE TURNOVER; CHROMATOGRAPHY; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; COST CONTROL; DENSITOMETRY; DIFFERENTIAL DIAGNOSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FACTORIAL ANALYSIS; FEMALE; HUMAN; HYDROLYSIS; OSTEOPENIA; PEPTIDE ANALYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE AND BONES; BONE RESORPTION; COLLAGEN; DENSITOMETRY, X-RAY; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE;

EID: 0037215033     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.013     Document Type: Article

References (12)

1. Palicka V, Jabor A, Friedecký B, Zivný P. Selected markers of bone biochemistry. Adv Clin Chem 2001; 35:255-94.
2. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 2000; Suppl 6:S2-17.
3. Beck-Jensen JE, Kollerup G, Soerensen HA, Pors Nielsen S, Soerensen OH. A single measurement of biochemical markers of bone turnover has limited utility in the individual persons. Scand J Clin Lab Invest 1997; 57:351-60.
4. Blumsohn A, Eastell R. The performance and utility of biochemical markers of bone turnover: Do we know enough to use them in clinical practice? Ann Clin Biochem 1997;34:449-59.
5. Mazzi G, Fioravanzo F, Burti E. New marker of bone resorption: hydroxyproline-containing peptide. HPLC assay without hydrolysis as an alternative to hydroxyproline determination: a preliminary report. J Chromatogr B 1996; 678:165-72.
6. Hušek P, Pohlídal A, Slabik D. Rapid screening of urinary proline-hydroxyproline dipeptide in bone turnover studies. J Chromatogr B 2002; 767:169-74.
7. Ju HS, Leung S, Brown B, Stringer MA, Leigh S, Scherrer Ch, et al. Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem 1997; 43:1570-6.
8. Jenkins DK. Deoxypyridinoline and telopeptides compared. Metra Review 1998; 11:1-8.
9. Vesper HW, Demers LM, Eastell R, Garnero P, Kleerekoper M, Robins SP, et al. Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline. Clin Chem 2002; 48:220-35.
10. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD. Different effects of bisphos-phonate and estrogen therapy of free and peptide-bound bone crosslinks excretion. J Bone Miner Res 1995; 10:641-9.
11. Apone S, Lee MY, Eyre DR. Osteoclasts generate crosslinked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone. Bone 1997;21:129-36.
12. Hušek P, Šimek P, Pohlídal A. Tracking a new biomarker of bone resorption. Proceedings of the 50th ASMS Conference, Orlando, FL, June 2002.